Number of the records: 1  

humanizované monoklonální protilátky

  1. Topical termhumanizované monoklonální protilátky
    See linkAntibodies, Humanized (UF)
    humánní monoklonální protilátky (UF)
    monoklonální protilátky humanizované (UF)
    See alsomonoklonální protilátky
    abciximab
    adalimumab
    alemtuzumab
    basiliximab
    bevacizumab
    brentuximab vedotin
    certolizumab pegol
    cetuximab
    daklizumab
    denosumab
    gemtuzumab
    inotuzumab ozogamicin
    ipilimumab
    natalizumab
    nivolumab
    omalizumab
    palivizumab
    panitumumab
    ranibizumab
    trastuzumab
    ustekinumab
    Linking entryAntibodies, Monoclonal, Humanized
    ConspectD12. - 776. - 124. - 486. - 485. - 114. - 224. - 060
    D12. - 776. - 124. - 790. - 651. - 114. - 224. - 060
    D12. - 776. - 377. - 715. - 548. - 114. - 224. - 200
    NoteAntibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
    DatabaseMESH
    References (23) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.